🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial studies how well onalespib works in treating patients w...
Status
Terminated
Location
Los Angeles County-USC Medical Center
Start Date
2016-04-04
Trial ID
NCT02572453
Treatments Being Tested
This phase Ib trial studies the side effects and best dose onalespib when g...
Status
Terminated
Location
University of Kentucky/Markey Cancer Center
Start Date
2016-01-15
Trial ID
NCT02474173
Treatments Being Tested
This phase I trial studies the side effects and best dose of olaparib and o...
Status
Completed
Location
Mayo Clinic Hospital in Arizona
Start Date
2017-05-19
Trial ID
NCT02898207
The purpose of this study is to investigate if an investigational drug call...
Status
Completed
Location
Arizona Cancer Center at UMC North
Start Date
2011-03
Trial ID
NCT01294202
Treatments Being Tested
A 2-part, Phase 1-2, open-label, parallel group, randomized study in patien...
Status
Completed
Location
University of California, Los Angeles Institute of Urologic Oncology
Start Date
2012-09
Trial ID
NCT01685268
Treatments Being Tested
AT13387/0001 is a dose-finding study of an experimental anticancer agent. I...
Status
Completed
Location
The University of Arizona Cancer Center
Start Date
2008-05
Trial ID
NCT00878423
This phase I trial studies the side effects and best dose of onalespib when...
Status
Terminated
Location
Massachusetts General Hospital Cancer Center
Start Date
2014-05-29
Trial ID
NCT02097225
Treatments Being Tested
This phase I trial studies the side effects and best dose of onalespib when...
Status
Completed
Location
Yale University
Start Date
2015-10-22
Trial ID
NCT02381535
This phase I trial studies the side effects and best dose of onalespib and ...
Status
Completed
Location
MedStar Georgetown University Hospital
Start Date
2016-09-30
Trial ID
NCT02503709
Treatments Being Tested
Background: \- The experimental drug AT13387 has been shown to have some a...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2010-11-19
Trial ID
NCT01246102
Treatments Being Tested